Skip to main content
OpenTrials

Clinical trial condition

Essential Thrombocythemia

Explore clinical trials studying Essential Thrombocythemia. Study availability and eligibility vary by location and protocol.

71 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Essential Thrombocythemia trial results

Completed

Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia

NCT02407080

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States
View Trial Details
Completed

Research Tissue Bank

NCT00666549

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • Palo Alto Medical Foundation Research Institute Palo Alto, California, United States
  • Weill Cornell University Washington D.C., District of Columbia, United States
  • University of Georgetown Washington D.C., District of Columbia, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
View Trial Details
Completed

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

NCT02311569

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
View Trial Details
Completed

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

NCT00718159

Conditions
Acute Myeloid Leukemia, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States
View Trial Details
Completed

Correlative Biomarker Study in Patients With Myeloproliferative Disorders

NCT00665067

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +16 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • The Palo Alto Clinic Palo Alto, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Emory Hospital Atlanta, Georgia, United States
View all 22 locations
View Trial Details
Completed

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

NCT00445744

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +39 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Familial Myeloproliferative Disorders

NCT00666289

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Mount Sinai School of Medicine New York, United States
  • Weill Cornell New York, United States
View Trial Details

Related conditions